Cargando…
O-GlcNAc Modification of NFκB p65 Inhibits TNF-α-Induced Inflammatory Mediator Expression in Rat Aortic Smooth Muscle Cells
BACKGROUND: We have shown that glucosamine (GlcN) or O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate (PUGNAc) treatment augments O-linked-N-acetylglucosamine (O-GlcNAc) protein modification and attenuates inflammatory mediator expression, leukocyte infiltration and neointima for...
Autores principales: | Xing, Dongqi, Gong, Kaizheng, Feng, Wenguang, Nozell, Susan E., Chen, Yiu-Fai, Chatham, John C., Oparil, Suzanne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164132/ https://www.ncbi.nlm.nih.gov/pubmed/21904602 http://dx.doi.org/10.1371/journal.pone.0024021 |
Ejemplares similares
-
Estrogen Modulates NFκB Signaling by Enhancing IκBα Levels and Blocking p65 Binding at the Promoters of Inflammatory Genes via Estrogen Receptor-β
por: Xing, Dongqi, et al.
Publicado: (2012) -
Enzyme-based assay for quantification of UDP-GlcNAc in cells and tissues
por: Chatham, John C., et al.
Publicado: (2023) -
The potential role of O-GlcNAc modification in cancer epigenetics
por: Forma, Ewa, et al.
Publicado: (2014) -
O-GlcNAc Modification and Its Role in Diabetic Retinopathy
por: Liu, Chengzhi, et al.
Publicado: (2022) -
O-GlcNAc modification: why so intimately associated with phosphorylation?
por: Mishra, Suresh, et al.
Publicado: (2011)